![1]()
News
C. difficile guidelines offer new possibilities
June 24, 2021
Updated recommendations address issues of diagnosis, recurrence, and fecal microbial transplant.
News
U.S., international MIS-C studies yield disparate results
June 18, 2021
The two real-world observational studies were published online in The New England Journal of Medicine.
![1]()
News
Microbiome therapeutic offers durable protection against C. difficile recurrence
May 28, 2021
“The hope would be that one or more ... would probably replace the vast majority of FMT [procedures] that we do clinically,”said Dr. Sahil Khanna.
News
Psoriasis associated with an increased risk of COVID-19 in real-world study
April 28, 2021
Those treated with TNF-alpha inhibitors, methotrexate, and apremilast had statistically lower risks of COVID-19 vs. those on topical therapy.
News
COVID-19’s impact on lupus inpatients examined in study
March 24, 2021
Younger inpatients with COVID-19 and SLE showed higher mortality than did COVID-19 inpatients of similar age from the general population in a French epidemiologic study.
![1]()
News
Neurologic disorders ubiquitous and rising in the U.S.
March 2, 2021
Most of the rise in disease burden could be attributed to population aging, while age-standardized figures showed stroke and dementias to be level or declining, offering hope that prevention measures may be having an effect.
![1]()
News
Rheumatologic disease activity an important influencer of COVID-19 death risk
February 5, 2021
COVID-19 Global Rheumatology Alliance physician registry data highlight need to maintain adequate disease control to lower risk for death from COVID-19.
News
Physicians react: Doctors worry about patients reading their clinical notes
January 11, 2021
As part of the 21st Century Cures Act, patients will now have the right to see their medical notes.
![1]()
News
COVID-19 vaccines: Safe for immunocompromised patients?
December 17, 2020
Data are limited thus far, and the safety and efficacy of the COVID-19 vaccines in immunocompromised patients remain unknown.
![1]()
News
COVID-19 risks in rheumatic disease remain unclear
November 7, 2020
Elevated COVID-19-related risks, many associated with comorbidities, emerged in a match-control study, whereas a systematic review delivers more encouraging news for people living with rheumatic disease.
